[go: up one dir, main page]

AU2001281843A1 - Dipeptide inhibitors for the blood-clotting factor Xa - Google Patents

Dipeptide inhibitors for the blood-clotting factor Xa

Info

Publication number
AU2001281843A1
AU2001281843A1 AU2001281843A AU2001281843A AU2001281843A1 AU 2001281843 A1 AU2001281843 A1 AU 2001281843A1 AU 2001281843 A AU2001281843 A AU 2001281843A AU 2001281843 A AU2001281843 A AU 2001281843A AU 2001281843 A1 AU2001281843 A1 AU 2001281843A1
Authority
AU
Australia
Prior art keywords
blood
clotting factor
dipeptide inhibitors
dipeptide
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001281843A
Other versions
AU2001281843B8 (en
AU2001281843B2 (en
Inventor
Sebastian Kunzel
Andrea Schweinitz
Torsten Steinmetzer
Jorg Sturzebecher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curacyte AG
Original Assignee
Curacyte AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10029015A external-priority patent/DE10029015A1/en
Application filed by Curacyte AG filed Critical Curacyte AG
Publication of AU2001281843A1 publication Critical patent/AU2001281843A1/en
Application granted granted Critical
Publication of AU2001281843B2 publication Critical patent/AU2001281843B2/en
Publication of AU2001281843B8 publication Critical patent/AU2001281843B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001281843A 2000-06-15 2001-06-15 Dipeptide inhibitors for the blood-clotting factor Xa Ceased AU2001281843B8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10029015A DE10029015A1 (en) 2000-06-15 2000-06-15 Coagulation Factor Xa inhibitor, useful for treatment, prophylaxis or diagnosis of thromboembolic disease, comprising acylated 3- or 4-amidino-benzylamine derivative
DE10029015.9 2000-06-15
PCT/EP2001/006814 WO2001096366A2 (en) 2000-06-15 2001-06-15 Dipeptide inhibitors for the blood-clotting factor xa

Publications (3)

Publication Number Publication Date
AU2001281843A1 true AU2001281843A1 (en) 2002-03-14
AU2001281843B2 AU2001281843B2 (en) 2005-06-09
AU2001281843B8 AU2001281843B8 (en) 2005-10-06

Family

ID=7645522

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001281843A Ceased AU2001281843B8 (en) 2000-06-15 2001-06-15 Dipeptide inhibitors for the blood-clotting factor Xa
AU8184301A Pending AU8184301A (en) 2000-06-15 2001-06-15 Inhibitors for the blood-clotting factor xa

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU8184301A Pending AU8184301A (en) 2000-06-15 2001-06-15 Inhibitors for the blood-clotting factor xa

Country Status (8)

Country Link
US (1) US6841701B2 (en)
EP (1) EP1294741B1 (en)
JP (1) JP2004503563A (en)
AT (1) ATE289319T1 (en)
AU (2) AU2001281843B8 (en)
CA (1) CA2412181A1 (en)
DE (2) DE10029015A1 (en)
WO (1) WO2001096366A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1182207B1 (en) * 2000-08-11 2007-04-18 Dendreon Corporation Non-covalent inhibitors of urokinase and blood vessel formation
IL149042A0 (en) * 2000-08-11 2002-11-10 Corvas Int Inc Non-covalent inhibitors of urokinase and blood vessel formation
ES2275937T3 (en) * 2001-12-12 2007-06-16 Wilex Ag SELECTIVE ARILGUANIDINE PEPTIDES AS UROCINASE INHIBITORS.
DE10210590A1 (en) * 2002-03-11 2003-10-02 Curacyte Ag Inhibitors of coagulation factor Xa, their production and use
US7838560B2 (en) 2002-03-11 2010-11-23 The Medicines Company (Leipzig) Gmbh Urokinase inhibitors, production and use thereof
DE10301300B4 (en) * 2003-01-15 2009-07-16 Curacyte Chemistry Gmbh Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
DE10342108A1 (en) * 2003-09-11 2005-04-14 Curacyte Chemistry Gmbh Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use
US20090286837A1 (en) * 2005-08-29 2009-11-19 Stefan Sperl Oxadiazole compounds as urokinase inhibitors
DE102005044319A1 (en) 2005-09-16 2007-03-22 Curacyte Chemistry Gmbh 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa
DE102006050672A1 (en) 2006-10-24 2008-04-30 Curacyte Discovery Gmbh New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
KR101503958B1 (en) * 2007-08-31 2015-03-18 디에스엠 아이피 어셋츠 비.브이. 4-amidino benzylamines for cosmetic and/or dermatological use
US8921319B2 (en) 2010-07-07 2014-12-30 The Medicines Company (Leipzig) Gmbh Serine protease inhibitors
AU2011349022B2 (en) 2010-12-21 2017-04-13 The Medicines Company (Leipzig) Gmbh Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (en) 1993-06-03 1993-06-03 Ab Astra NEW PEPTIDES DERIVATIVES
US5726159A (en) 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5705487A (en) 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
DE69532754T2 (en) 1994-04-26 2005-03-10 Aventis Pharmaceuticals, Inc. FACTOR XA INHIBITORS
KR100388185B1 (en) 1995-02-17 2003-11-28 애보트 게엠베하 운트 콤파니 카게 New dipeptide amidines as thrombin inhibitors
US5710130A (en) 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
FR2791683A1 (en) * 1999-03-30 2000-10-06 Synthelabo N-SULFONYL-DIPEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Similar Documents

Publication Publication Date Title
AU2001273040A1 (en) Factor xa inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2381600A (en) Thrombin or factor xa inhibitors
AU2002351179A1 (en) Glycinamides as factor xa inhibitors
AU2002365896A1 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
AU6007200A (en) Cysteine protease inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001293297A1 (en) Phyisological profiling
AU3074500A (en) Proteasome inhibitors
AU4723799A (en) Protease inhibitors
AU2001281843A1 (en) Dipeptide inhibitors for the blood-clotting factor Xa
AU2002322802A1 (en) Thrombin inhibitors
AU4092799A (en) Protease inhibitors
AU2003299901A1 (en) Thrombin inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU9110298A (en) Protease inhibitors
AU3235100A (en) Prothease inhibitors
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2002222933A1 (en) Inhibitors of factor xa
AU2001278997A1 (en) Thrombin inhibitors
AU2003296393A1 (en) Factor xa inhibitors
AU2713100A (en) Protease inhibitors
AU4564499A (en) Protease inhibitors